nach oben

Seminars in Immunopathology

Erschienen in:

01.12.2008 | Review

Human intrathymic development: a selective approach

verfasst von: J. Plum, M. De Smedt, G. Leclercq, T. Taghon, T. Kerre, B. Vandekerckhove

Erschienen in: Seminars in Immunopathology | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Human T lymphocytes can be generated from CD34 progenitor cells from different sources. This can be obtained in an in vivo model wherein human thymic tissue and fetal liver is transplanted in an immunodeficient mouse. However, human T cells are also generated in immunodeficient mice without co-transplantation of human thymus or in in vitro hybrid human–mouse fetal thymus organ culture. This shows that xenogeneic mouse thymus tissue supports human T cell differentiation. Finally, human T cells are generated on co-culture with murine stromal cells that express the Delta-like1 ligand for the Notch receptor. How these different environments influence the human T cell repertoire is reviewed and discussed.

Touraine JL, Roncarolo MG, Royo C et al (1987) Fetal tissue transplantation, bone marrow transplantation and prospective gene therapy in severe immunodeficiencies and enzyme deficiencies. Thymus 10:75–87PubMed

Hong R, Schulte-Wissermann H, Horowitz SD (1979) Thymic transplantation for relief of immunodeficiency diseases. Surg Clin North Am 59:299–312PubMed

Fischer A (2007) Human primary immunodeficiency diseases. Immunity 27:835–845. doi:10.1016/j.immuni.2007.11.012 PubMedCrossRef

Editorial (2008) Assessing the status of human immunology. Nat Immunol 9:569CrossRef

Payne KJ, Crooks GM (2007) Immune-cell lineage commitment: translation from mice to humans. Immunity 26:674–677 . doi:10.1016/j.immuni.2007.05.011 PubMedCrossRef

McCune JM, Namikawa R, Kaneshima H et al (1988) The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241:1632–1639. doi:10.1126/science.2971269 PubMedCrossRef

Fisher AG, Larsson L, Goff LK et al (1990) Human thymocyte development in mouse organ cultures. Int Immunol 2:571–578. doi:10.1093/intimm/2.6.571 PubMedCrossRef

Plum J, De Smedt M, Defresne MP et al (1994) Human CD34+ fetal liver stem cells differentiate to T cells in a mouse thymic microenvironment. Blood 84:1587–1593PubMed

Schmitt TM, Zuniga-Pflucker JC (2002) Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749–756. doi:10.1016/S1074-7613(02)00474-0 PubMedCrossRef

10.

La Motte-Mohs RN, Herer E, Zuniga-Pflucker JC (2005) Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood 105:1431–1439. doi:10.1182/blood-2004-04-1293 PubMedCrossRef

11.

Lanier LL, Allison JP, Phillips JH (1986) Correlation of cell surface antigen expression on human thymocytes by multi-color flow cytometric analysis: implications for differentiation. J Immunol 137:2501–2507PubMed

12.

Dik WA, Pike-Overzet K, Weerkamp F et al (2005) New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 201:1715–1723. doi:10.1084/jem.20042524 PubMedCrossRef

13.

Vanhecke D, Leclercq G, Plum J et al (1995) Characterization of distinct stages during the differentiation of human CD69+CD3+ thymocytes and identification of thymic emigrants. J Immunol 155:1862–1872PubMed

14.

Vanhecke D, Verhasselt B, De Smedt M et al (1997) MHC class II molecules are required for initiation of positive selection but not during terminal differentiation of human CD4 single positive thymocytes. J Immunol 158:3730–3737PubMed

15.

Vanhecke D, Verhasselt B, De Smedt M et al (1997) Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation. J Immunol 159:5973–5983PubMed

16.

Starr TK, Jameson SC, Hogquist KA (2003) Positive and negative selection of T cells. Annu Rev Immunol 21:139–176. doi:10.1146/annurev.immunol.21.120601.141107 PubMedCrossRef

17.

Goldrath AW, Bogatzki LY, Bevan MJ (2000) Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J Exp Med 192:557–564. doi:10.1084/jem.192.4.557 PubMedCrossRef

18.

Sandberg JK, Franksson L, Sundback J et al (2000) T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol 165:25–33PubMed

19.

Viret C, Wong FS, Janeway CA Jr (1999) Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition. Immunity 10:559–568. doi:10.1016/S1074-7613(00)80055-2 PubMedCrossRef

20.

Ernst B, Lee DS, Chang JM et al (1999) The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11:173–181. doi:10.1016/S1074-7613(00)80092-8 PubMedCrossRef

21.

Hemmer B, Pinilla C, Gran B et al (2000) Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency. J Immunol 164:861–871PubMed

22.

Mason D (1998) A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 19:395–404. doi:10.1016/S0167-5699(98)01299-7 PubMedCrossRef

23.

Bouneaud C, Kourilsky P, Bousso P (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13:829–840. doi:10.1016/S1074-7613(00)00080-7 PubMedCrossRef

24.

Romero P, Dunbar PR, Valmori D et al (1998) Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 188:1641–1650. doi:10.1084/jem.188.9.1641 PubMedCrossRef

25.

Coulie PG, Brichard V, Van Pel A et al (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35–42. doi:10.1084/jem.180.1.35 PubMedCrossRef

26.

Kawakami Y, Eliyahu S, Delgado CH et al (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458–6462. doi:10.1073/pnas.91.14.6458 PubMedCrossRef

27.

Romero P, Gervois N, Schneider J et al (1997) Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma. J Immunol 159:2366–2374PubMed

28.

Zippelius A, Bioley G, Le Gal FA et al (2004) Human thymus exports naive CD8 T cells that can home to nonlymphoid tissues. J Immunol 172:2773–2777PubMed

29.

Lima M, Almeida J, Santos AH et al (2001) Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol 159:1861–1868PubMed

30.

Fass D, Kim PS (1995) Dissection of a retrovirus envelope protein reveals structural similarity to influenza hemagglutinin. Curr Biol 5:1377–1383. doi:10.1016/S0960-9822(95)00275-2 PubMedCrossRef

31.

De Rossi A, Calabro ML, Panozzo M et al (1990) In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res Hum Retroviruses 6:287–298PubMed

32.

Vandekerckhove BA, Baccala R, Jones D et al (1992) Thymic selection of the human T cell receptor V beta repertoire in SCID-hu mice. J Exp Med 176:1619–1624. doi:10.1084/jem.176.6.1619 PubMedCrossRef

33.

Donahue JP, Ricalton NS, Behrendt CE et al (1994) Genetic analysis of low V beta 3 expression in humans. J Exp Med 179:1701–1706. doi:10.1084/jem.179.5.1701 PubMedCrossRef

34.

Tary-Lehmann M, Lehmann PV, Schols D et al (1994) Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 180:1817–1827. doi:10.1084/jem.180.5.1817 PubMedCrossRef

35.

Ishikawa F, Yasukawa M, Lyons B et al (2005) Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 106:1565–1573. doi:10.1182/blood-2005-02-0516 PubMedCrossRef

36.

Lin C, Chen S, Yang L et al (2007) Evaluation of TCR Vbeta subfamily T cell expansion in NOD/SCID mice transplanted with human cord blood hematopoietic stem cells. Hematology 12:325–330. doi:10.1080/10245330701342342 PubMedCrossRef

37.

Kerre TC, De Smet G, De Smedt M et al (2002) Adapted NOD/SCID model supports development of phenotypically and functionally mature T cells from human umbilical cord blood CD34(+) cells. Blood 99:1620–1626. doi:10.1182/blood.V99.5.1620 PubMedCrossRef

38.

Pflumio F, Lapidot T, Murdoch B et al (1993) Engraftment of human lymphoid cells into newborn SCID mice leads to graft-versus-host disease. Int Immunol 5:1509–1522. doi:10.1093/intimm/5.12.1509 PubMedCrossRef

39.

Hozumi N, Gorczynski R, Peters W et al (1994) A SCID mouse model for human immune response and disease. Res Immunol 145:370–379. doi:10.1016/S0923-2494(94)80202-5 PubMedCrossRef

40.

Kirberg J, Bosco N, Deloulme JC et al (2008) Peripheral T lymphocytes recirculating back into the thymus can mediate thymocyte positive selection. J Immunol 181:1207–1214PubMed

41.

Dai S, Huseby ES, Rubtsova K et al (2008) Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules. Immunity 28:324–334. doi:10.1016/j.immuni.2008.01.008 PubMedCrossRef

42.

Jerne NK (1971) The somatic generation of immune recognition. Eur J Immunol 1:1–9. doi:10.1002/eji.1830010102 PubMedCrossRef

43.

Van Laethem F, Sarafova SD, Park JH et al (2007) Deletion of CD4 and CD8 coreceptors permits generation of alphabetaT cells that recognize antigens independently of the MHC. Immunity 27:735–750PubMedCrossRef

44.

Moots RJ, Samberg NL, Pazmany L et al (1992) A cross-species functional interaction between the murine major histocompatibility complex class I alpha 3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes. Eur J Immunol 22:1643–1646. doi:10.1002/eji.1830220645 PubMedCrossRef

45.

Barzaga-Gilbert E, Grass D, Lawrance SK et al (1992) Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice. J Exp Med 175:1707–1715. doi:10.1084/jem.175.6.1707 PubMedCrossRef

46.

Vignali DA, Moreno J, Schiller D et al (1992) Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules. J Exp Med 175:925–932. doi:10.1084/jem.175.4.925 PubMedCrossRef

47.

Zinkernagel RM, Althage A (1999) On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells. Proc Natl Acad Sci USA 96:8092–8097. doi:10.1073/pnas.96.14.8092 PubMedCrossRef

48.

Park SH, Bae YM, Kim TJ et al (1992) HLA-DR expression in human fetal thymocytes. Hum Immunol 33:294–298. doi:10.1016/0198-8859(92)90338-N PubMedCrossRef

49.

Choi EY, Park WS, Jung KC et al (1997) Thymocytes positively select thymocytes in human system. Hum Immunol 54:15–20. doi:10.1016/S0198-8859(97)00012-8 PubMedCrossRef

50.

Choi EY, Jung KC, Park HJ et al (2005) Thymocyte–thymocyte interaction for efficient positive selection and maturation of CD4 T cells. Immunity 23:387–396. doi:10.1016/j.immuni.2005.09.005 PubMedCrossRef

51.

Li W, Sofi MH, Yeh N et al (2007) Thymic selection pathway regulates the effector function of CD4 T cells. J Exp Med 204:2145–2157PubMed

52.

Traggiai E, Chicha L, Mazzucchelli L et al (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104–107. doi:10.1126/science.1093933 PubMedCrossRef

53.

Legrand N, Weijer K, Spits H (2006) Experimental models to study development and function of the human immune system in vivo. J Immunol 176:2053–2058PubMed

54.

Saito Y, Kametani Y, Hozumi K et al (2002) The in vivo development of human T cells from CD34(+) cells in the murine thymic environment. Int Immunol 14:1113–1124. doi:10.1093/intimm/dxf087 PubMedCrossRef

55.

Radtke F, Wilson A, MacDonald HR (2004) Notch signaling in T- and B-cell development. Curr Opin Immunol 16:174–179. doi:10.1016/j.coi.2004.01.002 PubMedCrossRef

56.

Radtke F, Wilson A, Mancini SJ et al (2004) Notch regulation of lymphocyte development and function. Nat Immunol 5:247–253. doi:10.1038/ni1045 PubMedCrossRef

57.

de Pooter RF, Cho SK, Carlyle JR et al (2003) In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood 102:1649–1653. doi:10.1182/blood-2003-01-0224 PubMedCrossRef

58.

Jaleco AC, Neves H, Hooijberg E et al (2001) Differential effects of Notch ligands Delta-1 and Jagged-1 in human lymphoid differentiation. J Exp Med 194:991–1002. doi:10.1084/jem.194.7.991 PubMedCrossRef

59.

De Smedt M, Hoebeke I, Plum J (2004) Human bone marrow CD34+ progenitor cells mature to T cells on OP9-DL1 stromal cell line without thymus microenvironment. Blood Cells Mol Dis 33:227–232. doi:10.1016/j.bcmd.2004.08.007 PubMedCrossRef

60.

Awong G, La Motte-Mohs RN, Zuniga-Pflucker JC (2007) Generation of pro-T cells in vitro: potential for immune reconstitution. Semin Immunol 19:341–349. doi:10.1016/j.smim.2007.10.005 PubMedCrossRef

61.

De Smedt M, Reynvoet K, Kerre T et al (2002) Active form of Notch imposes T cell fate in human progenitor cells. J Immunol 169:3021–3029PubMed

62.

De Smedt M, Hoebeke I, Reynvoet K et al (2005) Different thresholds of Notch signaling bias human precursor cells toward B-, NK-, monocytic/dendritic-, or T-cell lineage in thymus microenvironment. Blood 106:3498–3506. doi:10.1182/blood-2005-02-0496 PubMedCrossRef

63.

Ciofani M, Zuniga-Pflucker JC (2007) The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol 23:463–493. doi:10.1146/annurev.cellbio.23.090506.123547 PubMedCrossRef

64.

Zhao Y, Parkhurst MR, Zheng Z et al (2007) Extrathymic generation of tumor-specific T cells from genetically engineered human hematopoietic stem cells via Notch signaling. Cancer Res 67:2425–2429. doi:10.1158/0008-5472.CAN-06-3977 PubMedCrossRef

65.

van Lent AU, Nagasawa M, van Loenen MM et al (2007) Functional human antigen-specific T cells produced in vitro using retroviral T cell receptor transfer into hematopoietic progenitors. J Immunol 179:4959–4968PubMed

66.

Besseyrias V, Fiorini E, Strobl LJ et al (2007) Hierarchy of Notch–Delta interactions promoting T cell lineage commitment and maturation. J Exp Med 204:331–343. doi:10.1084/jem.20061442 PubMedCrossRef

67.

Offner F, Van Beneden K, Debacker V et al (1997) Phenotypic and functional maturation of TCR gammadelta cells in the human thymus. J Immunol 158:4634–4641PubMed

68.

Jensen KD, Su X, Shin S et al (2008) Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29:90–100. doi:10.1016/j.immuni.2008.04.022 PubMedCrossRef

69.

Havran WL, Allison JP (1988) Developmentally ordered appearance of thymocytes expressing different T-cell antigen receptors. Nature 335:443–445. doi:10.1038/335443a0 PubMedCrossRef

70.

Boyden LM, Lewis JM, Barbee SD et al (2008) Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gammadelta T cells. Nat Genet 40:656–662. doi:10.1038/ng.108 PubMedCrossRef

Titel: Human intrathymic development: a selective approach
verfasst von: J. Plum
M. De Smedt
G. Leclercq
T. Taghon
T. Kerre
B. Vandekerckhove
Publikationsdatum: 01.12.2008
Verlag: Springer-Verlag
Erschienen in: Seminars in Immunopathology / Ausgabe 4/2008
Print ISSN: 1863-2297
Elektronische ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-008-0135-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

The immunopathology of thymic GVHD

The long road to the thymus: the generation, mobilization, and circulation of T-cell progenitors in mouse and man

Molecular mechanisms that control mouse and human TCR-αβ and TCR-γδ T cell development

Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches

Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation